1-1 of 1
Ruibin Wang
Close
Sort by
Journal Articles

Impact of ibrutinib dose adjustment on TTNT in first-line CLL/SLL: a real-world analysis using target trial emulation

Nilanjan Ghosh, Ruibin Wang, Zaina P. Qureshi, Zhijie Ding, Marie-Hélène Lafeuille, Bruno Emond, Bronwyn Moore, Jinghua He, Alex Bokun, Heena Mavani, Kerry A. Rogers
Journal: Blood Neoplasia
Blood Neoplasia (2024) 1 (3): 100022.
https://doi.org/10.1016/j.bneo.2024.100022
Published: 2024
Includes: Supplemental data